Sartorius: 'Overproportionate' earnings growth led by US single-use uptake

By Dan Stanton contact

- Last updated on GMT

Sartorius: Significant double-digit growth led by US single-use uptake

Related tags: Marketing

Gains in market share and better-than-expected market environment drove year-on-year sales growth of 36% for Sartorius’s bioprocessing business.

Sartorius published its nine-month 2015 figures today, and total sales across the group rose 29% on the same period last year to €830m ($943m).

But its Bioprocess Solutions sector, which comprises upstream and downstream biomanufacturing equipment and services, specialising in single-use systems, fared even stronger with sales up 36% to €605m and order intake up 39% to €637m.

The firm described these earnings as “overproportionate,”​ and CEO Joachim Kreuzburg attributed them “on the one hand to the excellent and better-than-expected market environment and, on the other hand, to our ongoing gains in market share.”

The firm also noted that all regions saw significant double-digit growth, but high-lighted the 55% year-on-year increase in the Americas region for the nine months, with the growth reaching 58% for the third quarter itself.

This supports a BCC Research report published in July​ suggesting the US will catch-up with - and overtake - Europe in implementing single-use technologies.

Related news

Show more

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Related suppliers

Follow us

Products

View more

Webinars